FDA Hold-Up: Opko Scrambles To Fix Problems At Manufacturing Site
This article was originally published in The Pink Sheet Daily
Executive Summary
Contract manufacturer Catalent Pharma is under the gun to prepare an action plan after FDA’s complete response letter on vitamin D drug Rayaldee (calcifediol).